Tennis Elbow in NYC: Why Regenerative Medicine Outperforms Steroid Injections
Tennis Elbow: More Than an Athletic Injury
Lateral epicondylitis — colloquially called "tennis elbow" — is one of the most common musculoskeletal conditions treated at Regen Health Physicians NYC. Despite the name, only about 5% of cases occur in tennis players. The condition affects office workers, surgeons, manual laborers, musicians, and anyone who performs repetitive gripping, lifting, or wrist extension movements.
The defining feature of tennis elbow is pain at the lateral epicondyle (the bony protrusion on the outer elbow) — the attachment point for the extensor carpi radialis brevis (ECRB) and other forearm extensor muscles. What begins as activity-related pain can progress to constant discomfort, grip weakness, and significant functional impairment.
At Regen Health Physicians, we treat lateral epicondylitis with a regenerative approach backed by strong clinical evidence.
Why Tennis Elbow Persists
The pathology of tennis elbow is not primarily inflammatory (despite the "-itis" suffix). Histological studies consistently show that chronic lateral epicondylitis involves tendinosis — degenerative changes in the tendon tissue characterized by:
- Angiofibroblastic degeneration (immature, disorganized collagen)
- Absence of inflammatory cells
- Neovascularization with associated nerve ingrowth (which drives the pain)
This distinction matters clinically. Anti-inflammatory treatments — including corticosteroid injections — are biologically mismatched to a condition that is fundamentally degenerative, not inflammatory. This is why the benefits of cortisone are typically short-lived.
The Problem With Corticosteroid Injections
Cortisone injections have long been the go-to "quick fix" for tennis elbow. They reduce pain — but temporarily. Multiple high-quality studies have documented a troubling pattern:
- Short-term: Corticosteroids reduce pain at 4–8 weeks
- Medium-term: By 12 weeks, the corticosteroid group begins to fall behind
- Long-term: At 1 year, patients who received corticosteroids have worse outcomes than those who received physical therapy or placebo
Repeated cortisone injections also carry real risks: tendon weakening, collagen disorganization, local fat atrophy, and skin depigmentation. A tendon that has been repeatedly injected with steroids becomes more fragile, not less.
The PRP Advantage for Tennis Elbow
Platelet-rich plasma therapy is biologically matched to the pathology of tennis elbow. PRP delivers concentrated growth factors — PDGF, TGF-β, EGF, FGF — directly to the degenerative tendon tissue, stimulating fibroblast proliferation and the synthesis of organized type I collagen (the structural collagen appropriate to tendons).
The Clinical Evidence
The evidence for PRP in lateral epicondylitis is among the strongest in the entire musculoskeletal PRP literature. Key studies include:
- Gosens et al. (2011) — A landmark double-blind RCT in American Journal of Sports Medicine found PRP superior to corticosteroid injection at both 6 and 12 months
- Krogh et al. (2013) — PRP superior to glucocorticoid and saline injections for pain at 3 months
- JAMA meta-analysis (2014) — PRP demonstrated superiority over corticosteroid for elbow tendinopathy at 1 year
The pattern is consistent: corticosteroids win at 4–8 weeks; PRP wins at 6, 12, and 24 months. For a condition that is inherently chronic, durable improvement is what matters.
What PRP Treatment for Tennis Elbow Looks Like at RHPNY
At Regen Health Physicians, the PRP procedure for tennis elbow is performed as an outpatient visit:
- Blood draw: A small sample is drawn from your arm
- Centrifugation: The sample is spun to concentrate platelets (typically 5–7x baseline concentration)
- Ultrasound-guided injection: Dr. Dhaliwal uses real-time ultrasound imaging to confirm precise delivery to the degenerative tendon insertion
The injection is performed with local anesthetic to minimize discomfort. Most patients experience 2–5 days of increased soreness as the growth factor cascade initiates. Progressive improvement typically follows over 6–12 weeks. A single PRP injection is frequently sufficient; a second injection 6–8 weeks later may be recommended for severe or long-standing cases.
Post-injection, a structured rehabilitation protocol focuses on eccentric strengthening of the forearm extensors — an evidence-based adjunct that maximizes the quality of tendon remodeling.
Peptide Adjunct
For patients with severe tendon degeneration or slow healing response, BPC-157 peptide therapy may be considered as an adjunct. BPC-157 has demonstrated tendon healing effects in preclinical studies and is available through RHPNY's peptide program.
If you have been dealing with lateral elbow pain and haven't found lasting relief, book a consultation at Regen Health Physicians NYC to discuss whether PRP therapy is appropriate for your case.
---
Medical Disclaimer: PRP therapy is not FDA-approved for lateral epicondylitis. This article is for educational purposes only. Individual results vary. Consult a qualified physician before beginning any treatment.
